TrialPanorama/TrialPanorama-database huggingface dataset:
Study NCT02276027 — Predictive Biomarker (PRD): ROS1 mRNA
Genes: ROS1; MCF3; ROS
Study NCT04023929 — Surrogate Endpoint (SUR): Serum bactericidal antibody
Study NCT00813969 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study NCT00175773 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01588587 — Predictive Biomarker (PRD): AGER mRNA
Genes: AGER; RAGE
Study NCT01588587 — Pharmacodynamic Biomarker (PDY): Dipeptidyl peptidase 4
Genes: DPP4; ADCP2; CD26
Study NCT01586624 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT04393155 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT04393155 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT04393155 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT04393155 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT04393155 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT04393155 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Interleukin 8
Genes: CXCL8; IL8
Study NCT04393155 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Interferon gamma
Genes: IFNG
Study NCT04393155 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT04393155 — Safety Biomarker (SAF): Interleukin 1
Study NCT02458898 — Monitoring Biomarker (MOI): Tissue transglutaminase
Genes: TGM2
Study NCT03390101 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Interleukin 17
Genes: IL17A; CTLA8; IL17
Study NCT02530814 — Predictive Biomarker (PRD): DDT mRNA
Genes: DDT
Study NCT03156036 — Predictive Biomarker (PRD): O-6-methylguanine-DNA-alkyltransferase
Genes: MGMT
Study NCT02631044 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT02506738 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01670578 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT00863668 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT03230968 — Predictive Biomarker (PRD): AIRE mRNA
Genes: AIRE; APECED
Study NCT02357615 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03459859 — Predictive Biomarker (PRD): NEDD8 mRNA
Genes: NEDD8
Study NCT01120600 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT02123069 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02197169 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Interferon gamma
Genes: IFNG
Study NCT00797433 — Surrogate Endpoint (SUR): Serum testosterone
Study NCT04179409 — Predictive Biomarker (PRD): DMD mRNA
Genes: DMD
Study NCT02587247 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT02587247 — Monitoring Biomarker (MOI): Carcinoembryonic antigen CEA
Genes: CEACAM5; CEA
Study NCT00315757 — Predictive Biomarker (PRD): TNFSF10 mRNA
Genes: TNFSF10; APO2L; TRAIL
Study NCT04148144 — Predictive Biomarker (PRD): LBP mRNA
Genes: LBP
Study NCT01934543 — Predictive Biomarker (PRD): MTTP mRNA
Genes: MTTP; MTP
Study NCT02586883 — Predictive Biomarker (PRD): CFTR mRNA
Genes: CFTR; ABCC7
Study NCT02586883 — Predictive Biomarker (PRD): SLC26A9 mRNA
Genes: SLC26A9
Study NCT04166669 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study NCT03276910 — Predictive Biomarker (PRD): ERFE mRNA
Genes: ERFE; C1QTNF15; CTRP15; FAM132B
Study NCT02585570 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00205036 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT03448679 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Serum albumin
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study NCT02620020 — Predictive Biomarker (PRD): LBP mRNA
Genes: LBP
Study NCT01813734 — Predictive Biomarker (PRD): RET mRNA
Genes: RET; CDHF12; CDHR16; PTC; RET51
Study NCT02299505 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study NCT02561988 — Predictive Biomarker (PRD): KIT mRNA
Genes: KIT; SCFR
Study NCT05990205 — Predictive Biomarker (PRD): SLC16A11 mRNA
Genes: SLC16A11; MCT11
Study NCT03860935 — Predictive Biomarker (PRD): TTR mRNA
Genes: TTR; PALB
Study NCT01293565 — Predictive Biomarker (PRD): EDA mRNA
Genes: EDA; ED1; EDA2
Study NCT02252367 — Predictive Biomarker (PRD): PDE5A mRNA
Genes: PDE5A; PDE5
Study NCT02252367 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Interleukin 8
Genes: CXCL8; IL8
Study NCT03218410 — Surrogate Endpoint (SUR): Pulmonary vascular resistance
Study NCT02186301 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT01343823 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT03652623 — Predictive Biomarker (PRD): SRY mRNA
Genes: SRY; TDF
Study NCT01605149 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT04469829 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04469829 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT04469829 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study NCT01508351 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02565485 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03583905 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00195650 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT02612831 — Safety Biomarker (SAF): 51Cr-EDTA
Study NCT04699643 — Predictive Biomarker (PRD): FGFR4 mRNA
Genes: FGFR4; JTK2; TKF
Study NCT00880464 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT01776125 — Predictive Biomarker (PRD): NF1 mRNA
Genes: NF1
Study NCT01503359 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study NCT05215704 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT01065584 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT02820961 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT04551352 — Predictive Biomarker (PRD): TYRP1 mRNA
Genes: TYRP1; CAS2; TYRP; TYRRP
Study NCT01768429 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03967691 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT03904680 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT03904680 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00603044 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT00603044 — Predictive Biomarker (PRD): Forkhead box protein P3
Genes: FOXP3; IPEX; JM2
Study NCT00625001 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT00661986 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03241433 — Predictive Biomarker (PRD): SIT1 mRNA
Genes: SIT1; SIT
Study NCT02917083 — Predictive Biomarker (PRD): Lymphocyte activation antigen CD30
Genes: TNFRSF8; CD30; D1S166E
Study NCT01802840 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT04268030 — Pharmacodynamic Biomarker (PDY): Lysosomal acid glucosylceramidase
Genes: GBA1; GBA; GC; GLUC
Study NCT03202654 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT03245190 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT02224118 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03580759 — Predictive Biomarker (PRD): MCC mRNA
Genes: MCC
Study NCT03907618 — Predictive Biomarker (PRD): AMH mRNA
Genes: AMH; MIF
Study NCT00927485 — Predictive Biomarker (PRD): FAP mRNA
Genes: FAP
Study NCT04111978 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT03940976 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT02273739 — Predictive Biomarker (PRD): IDH2 mRNA
Genes: IDH2
Study NCT01492101 — Predictive Biomarker (PRD): NKTR mRNA
Genes: NKTR
Study NCT01668277 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01668277 — Surrogate Endpoint (SUR): Pulmonary vascular resistance
Study NCT01224782 — Predictive Biomarker (PRD): Intact parathyroid hormone
Study NCT00184457 — Surrogate Endpoint (SUR): Serum testosterone
Study NCT02214498 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT02214498 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03450330 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT03952390 — Pharmacodynamic Biomarker (PDY): Angiotensinogenase renin
Genes: REN
Study NCT00908284 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT02828748 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT04286217 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04514614 — Predictive Biomarker (PRD): FAP mRNA
Genes: FAP
Study NCT00302393 — Safety Biomarker (SAF): SLC6A3
Genes: DAT
Study NCT00340535 — Safety Biomarker (SAF): Cytochrome P450 2D6
Genes: CYP2D6; CYP2DL1
Study NCT00340535 — Predictive Biomarker (PRD): CYP2E1 mRNA
Genes: CYP2E1; CYP2E
Study NCT00441688 — Predictive Biomarker (PRD): HLA-B mRNA
Genes: HLA-B; HLAB
Study NCT00441688 — Predictive Biomarker (PRD); Safety Biomarker (SAF): HLA-B
Genes: AS
Study NCT02249247 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT03157570 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT00129909 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04365101 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study NCT04604925 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04540120 — Predictive Biomarker (PRD): NLRP3 mRNA
Genes: NLRP3; C1orf7; CIAS1; NALP3; PYPAF1
Study NCT04513626 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT02571725 — Predictive Biomarker (PRD): BRCA1 mRNA
Genes: BRCA1; RNF53
Study NCT02571725 — Predictive Biomarker (PRD): BRCA2 mRNA
Genes: BRCA2; FACD; FANCD1
Study NCT00324103 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT02577042 — Safety Biomarker (SAF): Hemoglobin scavenger receptor
Genes: CD163; M130
Study NCT02577042 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT02577042 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study NCT04106414 — Predictive Biomarker (PRD): Indoleamine 2,3-dioxygenase 1
Genes: IDO1; IDO; INDO
Study NCT01097902 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Interleukin 8
Genes: CXCL8; IL8
Study NCT01552434 — Pharmacodynamic Biomarker (PDY): Valproic acid
Study NCT01279590 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT01279590 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study NCT01503671 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT04407572 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Monitoring Biomarker (MOI): Vitamin B12
Study NCT02229656 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT04121624 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04743050 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT04743050 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03381729 — Pharmacodynamic Biomarker (PDY): Survival motor neuron protein
Genes: SMN1; SMN; SMNT;; SMN2; SMNC
Study NCT00164970 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Monitoring Biomarker (MOI): Vitamin B12
Study NCT04567563 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT04567563 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study NCT03046420 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00342355 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT01832961 — Predictive Biomarker (PRD): Exhaled nitric oxide
Study NCT02300649 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00167869 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00155961 — Predictive Biomarker (PRD): TBXT mRNA
Genes: TBXT; T
Study NCT00155961 — Surrogate Endpoint (SUR): Serum testosterone
Study NCT00155961 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT00591578 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03153410 — Predictive Biomarker (PRD): CSF1R mRNA
Genes: CSF1R; FMS
Study NCT03219463 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT02531516 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT02934386 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00527488 — Predictive Biomarker (PRD): Hormone receptor
Study NCT01958827 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT03343418 — Pharmacodynamic Biomarker (PDY): Blood coagulation
Study NCT03471572 — Predictive Biomarker (PRD): BRCA1 mRNA
Genes: BRCA1; RNF53
Study NCT03471572 — Predictive Biomarker (PRD): BRCA2 mRNA
Genes: BRCA2; FACD; FANCD1
Study NCT02850705 — Predictive Biomarker (PRD): AQP4 mRNA
Genes: AQP4
Study NCT00778830 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT01771029 — Monitoring Biomarker (MOI): Procalcitonin
Study NCT01397097 — Predictive Biomarker (PRD): ENG mRNA
Genes: ENG; END
Study NCT02850302 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT02850302 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT02185521 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00327470 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study NCT03796299 — Predictive Biomarker (PRD): MCM5 mRNA
Genes: MCM5; CDC46
Study NCT01998971 — Predictive Biomarker (PRD): CD38 mRNA
Genes: CD38
Study NCT03424005 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT03424005 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT03424005 — Predictive Biomarker (PRD): PIK3CA mRNA
Genes: PIK3CA
Study NCT03424005 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study NCT01918254 — Predictive Biomarker (PRD): ERBB3 mRNA
Genes: ERBB3; HER3
Study NCT01918254 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT00270894 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04317690 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04379492 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT02464878 — Predictive Biomarker (PRD): SERPINA1 mRNA
Genes: SERPINA1; AAT; PI; PRO0684; PRO2209
Study NCT01521884 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT00768339 — Predictive Biomarker (PRD): XIAP mRNA
Genes: XIAP; API3; BIRC4; IAP3
Study NCT00775164 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00877773 — Predictive Biomarker (PRD); Safety Biomarker (SAF): PIK3CA
Genes: PI3K
Study NCT00877773 — Predictive Biomarker (PRD): Phosphatase and tensin homolog
Genes: PTEN; MMAC1; TEP1
Study NCT04135911 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04369820 — Predictive Biomarker (PRD): C5AR2 mRNA
Genes: C5AR2; C5L2; GPR77
Study NCT01495988 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT04655521 — Predictive Biomarker (PRD): TNFSF10 mRNA
Genes: TNFSF10; APO2L; TRAIL
Study NCT04655521 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT03062865 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT02250508 — Safety Biomarker (SAF): von Willebrand factor
Genes: VWF; F8VWF
Study NCT02065271 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study NCT02065271 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT02065271 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT01926327 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT01525199 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT04089943 — Predictive Biomarker (PRD); Safety Biomarker (SAF): miR-210
Genes: MIR210
Study NCT00928811 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Interleukin 2 receptor alpha
Genes: IL2RA
Study NCT02524106 — Predictive Biomarker (PRD): PCSK9 mRNA
Genes: PCSK9; NARC1; PSEC0052
Study NCT02016014 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01769911 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT01769911 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study NCT02268045 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT01193296 — Pharmacodynamic Biomarker (PDY): Dipeptidyl peptidase 4
Genes: DPP4; ADCP2; CD26
Study NCT04517357 — Monitoring Biomarker (MOI): Ovarian carcinoma antigen CA125
Genes: MUC16; CA125
Study NCT04280770 — Predictive Biomarker (PRD): PVR mRNA
Genes: PVR; PVS
Study NCT03687099 — Predictive Biomarker (PRD): PTPRC mRNA
Genes: PTPRC; CD45
Study NCT03687099 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT00541190 — Predictive Biomarker (PRD): CFTR mRNA
Genes: CFTR; ABCC7
Study NCT03611842 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Metalloproteinase inhibitor 1
Genes: TIMP1; CLGI; TIMP
Study NCT00673322 — Monitoring Biomarker (MOI): Carcinoembryonic antigen CEA
Genes: CEACAM5; CEA
Study NCT02810990 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase ABL1
Genes: ABL1; ABL; JTK7
Study NCT00057707 — Predictive Biomarker (PRD): COMT mRNA
Genes: COMT
Study NCT00188188 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT04103281 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT01287754 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT01287754 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT00923364 — Predictive Biomarker (PRD): GATA2 mRNA
Genes: GATA2
Study NCT00923364 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT03696784 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT03696784 — Predictive Biomarker (PRD): CASP9
Genes: MCH6; ICE-LAP6; APAF-3; PPP1R56
Study NCT03818269 — Predictive Biomarker (PRD): CP mRNA
Genes: CP
Study NCT02816164 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT01191879 — Predictive Biomarker (PRD); Safety Biomarker (SAF): TP53
Genes: p53; LFS1
Study NCT01191879 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Cellular tumor antigen p53
Genes: TP53; P53
Study NCT01843647 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT01843647 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT00998062 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT00998062 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT03010436 — Predictive Biomarker (PRD): Interleukin 5
Genes: IL5
Study NCT03597646 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT00000402 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03719729 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study NCT01953588 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT03612453 — Safety Biomarker (SAF): Reactive oxygen species
Study NCT00502840 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT04355715 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT03040570 — Predictive Biomarker (PRD): Hypoxia-inducible factor 1-alpha
Genes: HIF1A; BHLHE78; MOP1; PASD8
Study NCT03823365 — Predictive Biomarker (PRD): CD28 mRNA
Genes: CD28
Study NCT03823365 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT03823365 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT03823365 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT00409175 — Predictive Biomarker (PRD): TTR mRNA
Genes: TTR; PALB
Study NCT02101814 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT02101814 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT02101814 — Predictive Biomarker (PRD): NPY mRNA
Genes: NPY
Study NCT02101814 — Predictive Biomarker (PRD): POMC
Genes: MSH; POC; CLIP; ACTH; NPP; LPH
Study NCT02101814 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02101814 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT02101814 — Predictive Biomarker (PRD): IL6
Genes: IL-6; BSF2; HGF; HSF
Study NCT02101814 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 10
Genes: IL10
Study NCT02101814 — Safety Biomarker (SAF): Plasminogen activator inhibitor
Genes: SERPINE1; PAI1; PLANH1
Study NCT02101814 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Intercellular adhesion molecule 1
Genes: ICAM1
Study NCT00041587 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): Interleukin 13
Genes: IL13; NC30
Study NCT01193959 — Predictive Biomarker (PRD): Thymidylate synthase 
Genes: TYMS; TS; OK/SW-cl.29
Study NCT01193959 — Predictive Biomarker (PRD): DHFR mRNA
Genes: DHFR
Study NCT01193959 — Predictive Biomarker (PRD): ATIC mRNA
Genes: ATIC; PURH; OK/SW-cl.86
Study NCT01193959 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT01193959 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT01193959 — Predictive Biomarker (PRD): MYC mRNA
Genes: MYC; BHLHE39
Study NCT01193959 — Predictive Biomarker (PRD): PIK3CA mRNA
Genes: PIK3CA
Study NCT01193959 — Safety Biomarker (SAF): DHFR
Genes: DHFR1
Study NCT01193959 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT00495638 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study NCT00495638 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00995618 — Surrogate Endpoint (SUR): Serum uric acid
Study NCT03471403 — Predictive Biomarker (PRD): FAP mRNA
Genes: FAP
Study NCT01889862 — Surrogate Endpoint (SUR): Plasma phenylalanine